168 related articles for article (PubMed ID: 2686529)
1. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
2. Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor alpha genes in chemically transformed rat liver epithelial cells.
Lee LW; Raymond VW; Tsao MS; Lee DC; Earp HS; Grisham JW
Cancer Res; 1991 Oct; 51(19):5238-44. PubMed ID: 1717143
[TBL] [Abstract][Full Text] [Related]
3. N-myc oncogene enhances mitogenic responsiveness of diploid human fibroblasts to growth factors but fails to immortalize.
Brondyk WH; Boeckman FA; Fahl WE
Oncogene; 1991 Jul; 6(7):1269-76. PubMed ID: 1861869
[TBL] [Abstract][Full Text] [Related]
4. Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements.
Madsen MW; Lykkesfeldt AE; Laursen I; Nielsen KV; Briand P
Cancer Res; 1992 Mar; 52(5):1210-7. PubMed ID: 1737382
[TBL] [Abstract][Full Text] [Related]
5. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.
Le Roy X; Escot C; Brouillet JP; Theillet C; Maudelonde T; Simony-Lafontaine J; Pujol H; Rochefort H
Oncogene; 1991 Mar; 6(3):431-7. PubMed ID: 1707153
[TBL] [Abstract][Full Text] [Related]
6. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
Omata-Yamada T; Yamada H; Lengyel P
J Cell Physiol; 1991 Nov; 149(2):214-21. PubMed ID: 1748716
[TBL] [Abstract][Full Text] [Related]
7. Sporadic amplification of the insulin-like growth factor 1 receptor gene in human breast tumors.
Berns EM; Klijn JG; van Staveren IL; Portengen H; Foekens JA
Cancer Res; 1992 Feb; 52(4):1036-9. PubMed ID: 1310636
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of MHC class I antigens is not a general mechanism for the increased tumorigenicity caused by c-myc amplification.
Dahllöf B
Oncogene; 1990 Mar; 5(3):433-5. PubMed ID: 2156210
[TBL] [Abstract][Full Text] [Related]
9. Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.
Burgart LJ; Robinson RA; Haddad SF; Moore SA
Mod Pathol; 1991 Mar; 4(2):183-6. PubMed ID: 1675468
[TBL] [Abstract][Full Text] [Related]
10. EJ/ras neoplastic transformation of simian virus 40-immortalized human uroepithelial cells: a rare event.
Christian BJ; Kao CH; Wu SQ; Meisner LF; Reznikoff CA
Cancer Res; 1990 Aug; 50(15):4779-86. PubMed ID: 2164447
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas.
Meyers SL; O'Brien MT; Smith T; Dudley JP
Cancer Res; 1990 Sep; 50(18):5911-8. PubMed ID: 1975511
[TBL] [Abstract][Full Text] [Related]
12. Establishment of the human BSMZ breast cancer cell line, which overexpresses the erbB-2 and c-myc genes.
Watanabe M; Tanaka H; Kamada M; Okano JH; Takahashi H; Uchida K; Iwamura A; Zeniya M; Ohno T
Cancer Res; 1992 Oct; 52(19):5178-82. PubMed ID: 1356615
[TBL] [Abstract][Full Text] [Related]
13. Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells?
Tang RP; Kacinski B; Validire P; Beuvon F; Sastre X; Benoit P; dela Rochefordière A; Mosseri V; Pouillart P; Scholl S
J Cell Biochem; 1990 Nov; 44(3):189-98. PubMed ID: 1980125
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
[TBL] [Abstract][Full Text] [Related]
15. Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene.
Lebeau J; Le Chalony C; Prosperi MT; Goubin G
Oncogene; 1991 Jul; 6(7):1125-32. PubMed ID: 1861862
[TBL] [Abstract][Full Text] [Related]
16. TGF-alpha production correlates with tumorigenicity in clones of the SW613-S human colon carcinoma cell line.
Modjtahedi N; Haddada H; Lamonerie T; Lazar E; Lavialle C; Brison O
Int J Cancer; 1992 Sep; 52(3):483-90. PubMed ID: 1399125
[TBL] [Abstract][Full Text] [Related]
17. Oncogene transformation frequency of nonsenescent SFME cells is increased by c-myc.
Rawson C; Shirahata S; Collodi P; Natsuno T; Barnes D
Oncogene; 1991 Mar; 6(3):487-9. PubMed ID: 2011405
[TBL] [Abstract][Full Text] [Related]
18. Alterations in growth properties of human papilloma virus type 16 immortalised human cervical keratinocyte cell line correlate with amplification and overexpression of c-myc oncogene.
Crook T; Greenfield I; Howard J; Stanley M
Oncogene; 1990 Apr; 5(4):619-22. PubMed ID: 2158040
[TBL] [Abstract][Full Text] [Related]
19. Human bronchial epithelial cells transformed by the c-raf-1 and c-myc protooncogenes induce multidifferentiated carcinomas in nude mice: a model for lung carcinogenesis.
Pfeifer AM; Jones RT; Bowden PE; Mann D; Spillare E; Klein-Szanto AJ; Trump BF; Harris CC
Cancer Res; 1991 Jul; 51(14):3793-801. PubMed ID: 1712250
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of c-myc proto-oncogene in primary human breast carcinomas.
Pavelic ZP; Steele P; Preisler HD
Anticancer Res; 1991; 11(4):1421-7. PubMed ID: 1660688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
